Lead optimisation
Hit to lead
Assay Development
Therapeutic area
  • Anti-microbial

Project Aim

To develop a novel small molecule TB therapeutic


Potent, selective and orally bioavailable compounds that will complement existing therapeutic approaches

Target Class

Enzyme (phosphatase)


Small molecule

Current Status


Intellectual Property

Opportunity to create a protective IPR portfolio


Licence or collaboration for preclinical / clinical development

Key Contact

  • In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. A backup of your data will be held but only authorised individuals will be able to access your data. If you would like your data to be removed, please email
    Please see our Privacy policy in relation to the personal data you submit to us through this page.
All Licensing Opportunities